Fortem Technologies closed an oversubscribed $50 million Series B led by Lockheed Martin on 30 September, valued below $1 billion. The round capitalises a counter-drone business anchored by a five-year Homeland Security vehicle worth $1.011 billion and an $18 million Army contract.
Positron AI closed an $875M Series C at a $5B valuation on a contrarian bet: skip high-bandwidth memory, put cheap LPDDR5X next to a custom datapath, and serve very long contexts from a single node. The chip that has to prove it is not in production yet.
What is a drug worth if the crystal it needs cannot form on Earth? Varda Space Industries put a number on that question on 30 September. The company closed a $251 million Series D co-led by Lux Capital and Natural Capital, at a $1.6 billion valuation, bringing total
Virtual cell AI from Arc Institute could reshape biological research and drug discovery with predictive models.
78% of new storage is built for four hours. The multi-day stack — iron-air, compressed air, pumped hydro — landed its biggest contracts and its first valuation resets in 2026. A comparison radar of where the next cost curve begins.
86% of 14 ASCO phase-3 calls posted the day before readout. That is the early proof point for a generative world model aimed at synergistic sequences, not single-target ranking.
Gradient-backed pre-seed for Nebula, a hierarchical state layer that lets long-horizon agents query current enterprise workflows instead of rebuilding context every turn.
Without a disclosed price, Wandercraft acquired Ekso Bionics from ChronoScale Holdings. Together they claim more than 700 rehabilitation centres, shared FDA clearances across four indications, and a catalogue that now runs from the clinic to the home to the factory floor.